article thumbnail

Antibiotic Minimum Inhibitory Concentrations: Do You know These 6 Things About Them?

IDStewardship

coli labeled as susceptible in 2010 may be labeled as resistant in 2025. MIC breakpoints can change over time CLSI and other similar bodies change breakpoints periodically based on epidemiological data and other emerging information. This means that the same E. CLSI releases updates on which breakpoints are changing and why.

Labelling 130
article thumbnail

Top 10 Journal Articles To Read During Your Infectious Diseases Pharmacy Rotation

IDStewardship

BCPS, BCIDP Article Posted 12 March 2023 As a pharmacist serving as a preceptor to students and residents in the area of infectious diseases since 2010, I have always been on the hunt for good infectious diseases journal articles for my learners to read. Authored by: Timothy P. Gauthier, Pharm.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 105
article thumbnail

Provention faces delay in FDA review of diabetes prevention antibody

pharmaphorum

The issues are holding up discussions between the agency and company about labeling and post-marketing requirements for teplizumab, and are concentrated around the pharmacokinetics data for the antibody, and whether it is comparable to the drug that its original developer Eli Lilly entered into clinical trials.

FDA 98
article thumbnail

Sanofi extends its Pompe range with first Nexviazyme OK

pharmaphorum

In 2010, Lumizyme’s label was expanded to the under-right group as well. Myozyme was first to market in 2006 for infantile-onset Pompe, with Lumizyme reaching the market four years later to treat late-onset Pompe in children aged over eight.

FDA 98
article thumbnail

Can you take Tylenol and Motrin together?

The Checkup by Singlecare

RELATED: Ibuprofen savings | Acetaminophen savings Multiple studies, including a 2010 study focused on pain treatment after oral surgery, found the alternating ibuprofen and acetaminophen to be successful. Follow the proper label instructions for each.

article thumbnail

High risk, high reward – the future of CAR-T therapy in CLL

Pharmaceutical Technology

In 2010, two patients with end-stage refractory chronic lymphocytic leukaemia (CLL) were administered Novartis’ autologous anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy, Kymriah (tisagenlecleucel), as part of a Phase I trial.